Evotec SE (EVO) Key Metrics
EVO key metrics, 2015–2025
Fiscal year ended December 31, 2025 · eurosEVO returns How much profit the business earns on the capital it uses.
EVO financial health Debt, liquidity and how easily interest is covered.
EVO efficiency & capital use Working capital cycle and where the cash goes.
EVO returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
EVO debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
EVO cash returned to shareholders
EVO key metrics in euros
2015–2025| 2025 | 2024 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns & profitability | ||||||||||
| Return on equity (ROE) | −11.3% | −20.6% | −13.7% | 19.0% | 0.9% | 8.0% | 22.3% | 8.9% | 13.8% | 8.9% |
| Return on invested capital (ROIC) | −12.0% | −11.3% | 1.6% | 3.9% | 3.0% | 7.6% | 19.2% | 12.8% | 27.2% | 15.8% |
| Return on assets (ROA) | −5.4% | −10.3% | −7.8% | 10.6% | 0.4% | 3.5% | 11.7% | 4.8% | 8.6% | 5.7% |
| Return on tangible assets | −6.7% | −12.2% | −9.0% | 11.1% | 0.4% | 4.0% | 19.7% | 7.8% | 11.7% | 7.6% |
| Free cash flow margin | −10.4% | −14.3% | 3.3% | 0.5% | −10.9% | 2.3% | 34.2% | −2.6% | 34.8% | 3.3% |
| Income quality (OCF / net income) | — | — | — | 0.57 | 7.12 | 1.11 | 1.86 | 0.45 | 2.45 | 0.95 |
| Financial health | ||||||||||
| Total debt | €447.5M | €443.5M | €506.7M | €512.9M | €601.9M | €519.8M | €114.5M | €189.9M | €28.8M | €22.9M |
| Cash & short-term investments | €476.2M | €396.8M | €707.3M | €858.5M | €589.7M | €359.2M | €149.9M | €101.6M | €127.9M | €135.0M |
| Net debt | −€28.7M | €46.7M | −€200.6M | −€345.6M | €12.3M | €160.6M | −€35.4M | €88.4M | −€99.0M | −€112.0M |
| Debt / equity | 0.55 | 0.47 | 0.43 | 0.37 | 0.68 | 0.97 | 0.27 | 0.57 | 0.14 | 0.12 |
| Debt / assets | 0.25 | 0.23 | 0.22 | 0.23 | 0.33 | 0.38 | 0.15 | 0.28 | 0.08 | 0.08 |
| Net debt / EBITDA | — | — | — | −1.09 | 0.14 | 1.85 | −0.33 | 2.49 | −2.17 | −4.49 |
| Current ratio | 2.07 | 1.98 | 3.18 | 3.39 | 3.16 | 2.62 | 1.27 | 0.73 | 2.31 | 2.96 |
| Quick ratio | 1.99 | 1.89 | 3.09 | 3.31 | 3.10 | 2.56 | 1.24 | 0.70 | 2.25 | 2.90 |
| Interest coverage | -9.8 | -12.2 | 1.6 | 4.4 | 5.7 | 8.4 | 29.9 | 29.7 | 20.6 | 6.7 |
| Working capital | €394.7M | €337.4M | €736.0M | €776.4M | €551.1M | €326.2M | €53.5M | −€65.5M | €95.8M | €110.5M |
| Invested capital | €784.7M | €999.3M | €986.5M | €1.03B | €898.7M | €696.1M | €388.6M | €419.1M | €114.0M | €73.5M |
| Tangible asset value | €509.6M | €643.2M | €888.5M | €1.09B | €463.8M | €116.9M | €81.1M | −€23.5M | €98.3M | €116.3M |
| Net current asset value | −€202.0M | −€278.0M | €3.6M | €243.5M | −€145.1M | −€317.3M | −€97.2M | −€155.3M | €31.8M | €65.5M |
| Capital allocation | ||||||||||
| Dividends paid | €0 | €0 | €0 | €0 | — | — | — | €1.7M | €2.0M | €551,000 |
| Share buybacks (net) | €1.5M | €0 | — | — | — | — | — | — | €17.6M | €0 |
| Dividend payout ratio | — | — | — | 0.0% | — | — | — | 7.1% | 7.3% | 3.3% |
| Dividends + buybacks / free cash flow | — | — | 0.0% | 0.0% | — | — | — | — | 34.2% | 13.3% |
| Capex / revenue | 9.2% | 16.6% | 24.1% | 19.2% | 19.8% | 7.1% | 7.4% | 6.8% | 6.2% | 9.0% |
| Capex / operating cash flow | — | 725.8% | 88.1% | 97.3% | 221.5% | 75.6% | 17.8% | 162.4% | 15.1% | 73.5% |
| Capex / depreciation | 0.73 | 1.30 | 2.18 | 1.76 | 1.77 | 0.65 | 0.89 | 0.85 | 0.85 | 0.96 |
| Stock-based compensation / revenue | 0.5% | 0.6% | 1.3% | 1.3% | 1.1% | 0.8% | 1.1% | 1.1% | 2.4% | 3.1% |
| R&D / revenue | 9.8% | 6.4% | 10.2% | 10.6% | 11.9% | 13.1% | 9.5% | 6.8% | 11.0% | 14.4% |
| SG&A / revenue | 23.2% | 23.6% | 19.0% | 15.5% | 13.5% | 12.8% | 15.2% | 16.5% | 16.4% | 19.7% |
| Efficiency | ||||||||||
| Days sales outstanding | 104.1 | 100.0 | 109.9 | 101.6 | 111.8 | 81.9 | 63.6 | 70.7 | 57.7 | 63.4 |
| Days of inventory on hand | 15.9 | 16.7 | 17.6 | 16.6 | 14.0 | 10.3 | 10.2 | 13.9 | 12.8 | 12.7 |
| Days payables outstanding | 39.5 | 45.9 | 53.7 | 48.8 | 42.4 | 38.6 | 39.6 | 39.7 | 41.6 | 49.5 |
| Cash conversion cycle (days) | 80.4 | 70.8 | 73.8 | 69.5 | 83.3 | 53.6 | 34.2 | 44.9 | 28.9 | 26.7 |
| Receivables turnover | 3.51 | 3.65 | 3.32 | 3.59 | 3.27 | 4.46 | 5.73 | 5.16 | 6.33 | 5.75 |
| Payables turnover | 9.23 | 7.95 | 6.80 | 7.48 | 8.60 | 9.46 | 9.21 | 9.20 | 8.77 | 7.37 |
| Inventory turnover | 22.99 | 21.92 | 20.76 | 22.00 | 26.16 | 35.38 | 35.89 | 26.28 | 28.49 | 28.63 |
| Asset turnover | 0.41 | 0.42 | 0.33 | 0.30 | 0.31 | 0.41 | 0.52 | 0.51 | 0.51 | 0.44 |
| Average receivables | €215.9M | €218.4M | €226.3M | €172.1M | €153.4M | €100.1M | €65.5M | €49.9M | €26.0M | €22.2M |
| Average payables | €75.3M | €85.8M | €84.9M | €62.3M | €43.6M | €33.1M | €28.6M | €19.0M | €12.1M | €12.2M |
| Average inventory | €30.2M | €31.1M | €27.8M | €21.2M | €14.3M | €8.9M | €7.3M | €6.7M | €3.7M | €3.1M |
| Intangibles / total assets | 17.1% | 16.2% | 13.2% | 12.9% | 23.0% | 30.3% | 44.5% | 53.2% | 32.9% | 24.5% |
Computed from EVO's annual financial statements (latest annual report filed April 8, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in euros; data from EODHD. Averages use the opening and closing balance of each year.
EVO valuation and financial ratios
Evotec earned a return on equity of −11.3% and a return on invested capital of −12.0% in fiscal 2025. It ended the year with €447.5 million of debt and €476.2 million in cash and short-term investments, a net cash position of €28.7 million. It returned €1.5 million to shareholders: €0 in dividends and €1.5 million in share buybacks.
See the EVO income statement, the EVO chart for price history, or the EVO stock overview for the latest quote and news.
EVO key metrics FAQ
What is Evotec's return on equity?
Evotec's return on equity (ROE) was −11.3% in fiscal 2025: net income of -€99.4 million on average shareholders' equity of €882.9 million.
What is Evotec's ROIC?
Evotec's return on invested capital was −12.0% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Evotec have?
Evotec had total debt of €447.5 million at the end of fiscal 2025, a debt-to-equity ratio of 0.55 and more cash than debt.
Does Evotec pay a dividend?
Evotec did not pay a dividend in fiscal 2025.
Does Evotec buy back its shares?
Yes. Evotec spent €1.5 million on net share repurchases in fiscal 2025.
What is Evotec's current ratio?
Evotec's current ratio was 2.07 at the end of fiscal 2025: current assets were 2.07 times current liabilities.